Landmark coronavirus study to trial inhaled Imperial and Oxford vaccines

Medical Research Council (MRC) sent this bulletin at 15-09-2020 10:01 AM BST

Home

Funding

Research

News

Having trouble viewing this email? Click here to view in a browser

Landmark coronavirus study to trial inhaled Imperial and Oxford vaccines

15-09-2020 12:00 AM BST

UKRI and NIHR funded researchers at Imperial College London are set to begin trials to assess the safety and effectiveness of two of the UK’s coronavirus vaccines in development, when inhaled into the lungs.

Manage preferences

Unsubscribe

Help

You are receiving this email because you subscribed to one or more of the Medical Research Council's email alerts using this address. We use third party service providers, such as GovDelivery, to send out email alerts on our behalf. The data you provided in subscribing to this alert (in this case your email address) will not be used for any other reason and will never be passed on to any other third party for another purpose. If you choose to enter a password to manage your subscription preferences this is held securely and is not accessible to anyone at either the MRC or GovDelivery.

STAY CONNECTED:

SUBSCRIBER SERVICES:
Manage Preferences | Unsubscribe | Contact us | Visit our blog | Help